Jane Street’s VanEck Vectors Generic Drugs ETF GNRX Stock Holding History

Jane Street’s Portfolio GNRX Stock Details GNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,145	Closed	-$271K	–	5843
2017 Q4	$271K	Buy	11,145 +336	+3%	+$7.83K	﹤0.01%	3884
2017 Q3	$239K	Buy	+10,809	New	+$239K	﹤0.01%	3945

Other funds holding GNRX

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street's GNRX Position: Q1 2018 in Review

Jane Street sold out of VanEck Vectors Generic Drugs ETF (GNRX) in Q1 2018, closing a stake of 11,145 shares — an estimated $271K sold.

Jane Street first reported a position in GNRX in Q3 2017 and held it in 2 quarters. The position peaked at $271K in Q4 2017. 2 funds tracked by Wall St. Rank hold GNRX as of Q1 2018.

Jane Street reported no remaining VanEck Vectors Generic Drugs ETF position as of Q1 2018 after selling out during the quarter.
Jane Street sold 11,145 VanEck Vectors Generic Drugs ETF shares in Q1 2018, an estimated $271K.
Jane Street first reported a position in VanEck Vectors Generic Drugs ETF in Q3 2017 and held it in 2 quarters.
Jane Street's VanEck Vectors Generic Drugs ETF position peaked at $271K in Q4 2017.
2 funds tracked by Wall St. Rank held VanEck Vectors Generic Drugs ETF as of Q1 2018.

Based on Jane Street's 13F filing for Q1 2018, filed 15 May 2018.